Peer review reports
From: Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1
Original Submission |
8 Jul 2023 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
25 Aug 2023 |
Reviewed |
Reviewer Report
|
8 Sep 2023 |
Reviewed |
Reviewer Report
|
20 Sep 2023 |
Author responded |
Author comments - Jiali Zhao
|
Resubmission - Version 4 |
20 Sep 2023 |
Submitted |
Manuscript version 4
|
21 Sep 2023 |
Author responded |
Author comments - Jiali Zhao
|
Resubmission - Version 5 |
21 Sep 2023 |
Submitted |
Manuscript version 5
|
21 Oct 2023 |
Reviewed |
Reviewer Report
|
1 Nov 2023 |
Reviewed |
Reviewer Report
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
Publishing |
4 Nov 2023 |
Editorially accepted |
|
6 Dec 2023 |
Article published |
10.1186/s12885-023-11613-8
|
Learn about peer review